Marshall Wace
CYTK icon

Marshall Wace’s Cytokinetics CYTK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$701K Sell
21,225
-2,007,567
-99% -$66.3M ﹤0.01% 1880
2025
Q1
$81.5M Sell
2,028,792
-124,521
-6% -$5M 0.1% 161
2024
Q4
$101M Buy
2,153,313
+279,612
+15% +$13.2M 0.12% 143
2024
Q3
$98.9M Buy
1,873,701
+195,542
+12% +$10.3M 0.12% 139
2024
Q2
$90.9M Sell
1,678,159
-878,644
-34% -$47.6M 0.12% 147
2024
Q1
$179M Buy
2,556,803
+1,930,716
+308% +$135M 0.27% 63
2023
Q4
$52.3M Sell
626,087
-907,882
-59% -$75.8M 0.09% 197
2023
Q3
$45.2M Buy
1,533,969
+1,278,577
+501% +$37.7M 0.09% 213
2023
Q2
$8.33M Sell
255,392
-489,915
-66% -$16M 0.02% 710
2023
Q1
$26.2M Sell
745,307
-266,155
-26% -$9.37M 0.06% 319
2022
Q4
$46.3M Buy
1,011,462
+55,576
+6% +$2.55M 0.1% 191
2022
Q3
$46.3M Sell
955,886
-397,251
-29% -$19.2M 0.1% 193
2022
Q2
$53.2M Buy
1,353,137
+1,322,232
+4,278% +$51.9M 0.11% 170
2022
Q1
$1.14M Sell
30,905
-13,266
-30% -$488K ﹤0.01% 1815
2021
Q4
$2.01M Buy
+44,171
New +$2.01M ﹤0.01% 1619
2021
Q3
Sell
-132,497
Closed -$2.62M 2468
2021
Q2
$2.62M Sell
132,497
-141,409
-52% -$2.8M 0.01% 1016
2021
Q1
$6.37M Buy
273,906
+221,628
+424% +$5.16M 0.03% 632
2020
Q4
$1.09M Sell
52,278
-155,175
-75% -$3.22M 0.01% 1063
2020
Q3
$4.49M Buy
+207,453
New +$4.49M 0.03% 522
2019
Q2
Sell
-7,996
Closed -$65K 1404
2019
Q1
$65K Hold
7,996
﹤0.01% 1486
2018
Q4
$51K Buy
+7,996
New +$51K ﹤0.01% 1434
2018
Q2
Sell
-30,600
Closed -$220K 725
2018
Q1
$220K Buy
+30,600
New +$220K 0.01% 509